Global Cell Therapy and Gene Therapy CDMO Market Growth (Status and Outlook) 2026-2032
The global Cell Therapy and Gene Therapy CDMO market size is predicted to grow from US$ 5067 million in 2025 to US$ 18530 million in 2032; it is expected to grow at a CAGR of 20.7% from 2026 to 2032.
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
United States market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell Therapy and Gene Therapy CDMO players cover Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell Therapy and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell Therapy and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy and Gene Therapy CDMO sales for 2026 through 2032. With Cell Therapy and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
United States market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell Therapy and Gene Therapy CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell Therapy and Gene Therapy CDMO players cover Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell Therapy and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell Therapy and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy and Gene Therapy CDMO sales for 2026 through 2032. With Cell Therapy and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell Therapy
- Gene Therapy
- Clinical Stage Projects
- Commercialization Stage Projects
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza Pharmaceuticals
- Thermo Fisher
- catalent
- Jubilant LifeSciences
- Boehringer Ingelheim
- Oxford BioMedica
- Charles River
- WuXi AppTec
- He Yuan Biology
- GenScript Biotech
- Kanglong Chemical
- Porton shares
- Sano Biologics
- Yunzhou Biology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy and Gene Therapy CDMO Segment by Type
2.2.1 Cell Therapy
2.2.2 Gene Therapy
2.2.3 Cell Therapy and Gene Therapy CDMO Market Size by Type
2.2.3.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy and Gene Therapy CDMO Segment by Application
2.3.1 Clinical Stage Projects
2.3.2 Commercialization Stage Projects
2.3.3 Cell Therapy and Gene Therapy CDMO Market Size by Application
2.3.3.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELL THERAPY AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell Therapy and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY AND GENE THERAPY CDMO BY REGION
4.1 Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cell Therapy and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy and Gene Therapy CDMO Forecast
10.1.3 APAC Cell Therapy and Gene Therapy CDMO Forecast
10.1.4 Europe Cell Therapy and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast
10.2 Americas Cell Therapy and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cell Therapy and Gene Therapy CDMO Forecast
10.3 APAC Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cell Therapy and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.5 India Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cell Therapy and Gene Therapy CDMO Forecast
10.4 Europe Cell Therapy and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.2 France Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.3 UK Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cell Therapy and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cell Therapy and Gene Therapy CDMO Forecast
10.6 Global Cell Therapy and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cell Therapy and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Information
11.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
11.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Pharmaceuticals Main Business Overview
11.1.5 Lonza Pharmaceuticals Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
11.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 catalent
11.3.1 catalent Company Information
11.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Offered
11.3.3 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 catalent Main Business Overview
11.3.5 catalent Latest Developments
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Information
11.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
11.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Jubilant LifeSciences Main Business Overview
11.4.5 Jubilant LifeSciences Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
11.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Information
11.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
11.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Oxford BioMedica Main Business Overview
11.6.5 Oxford BioMedica Latest Developments
11.7 Charles River
11.7.1 Charles River Company Information
11.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Offered
11.7.3 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Charles River Main Business Overview
11.7.5 Charles River Latest Developments
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Information
11.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
11.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 WuXi AppTec Main Business Overview
11.8.5 WuXi AppTec Latest Developments
11.9 He Yuan Biology
11.9.1 He Yuan Biology Company Information
11.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
11.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 He Yuan Biology Main Business Overview
11.9.5 He Yuan Biology Latest Developments
11.10 GenScript Biotech
11.10.1 GenScript Biotech Company Information
11.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
11.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 GenScript Biotech Main Business Overview
11.10.5 GenScript Biotech Latest Developments
11.11 Kanglong Chemical
11.11.1 Kanglong Chemical Company Information
11.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
11.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Kanglong Chemical Main Business Overview
11.11.5 Kanglong Chemical Latest Developments
11.12 Porton shares
11.12.1 Porton shares Company Information
11.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
11.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Porton shares Main Business Overview
11.12.5 Porton shares Latest Developments
11.13 Sano Biologics
11.13.1 Sano Biologics Company Information
11.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
11.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sano Biologics Main Business Overview
11.13.5 Sano Biologics Latest Developments
11.14 Yunzhou Biology
11.14.1 Yunzhou Biology Company Information
11.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
11.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Yunzhou Biology Main Business Overview
11.14.5 Yunzhou Biology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy and Gene Therapy CDMO Segment by Type
2.2.1 Cell Therapy
2.2.2 Gene Therapy
2.2.3 Cell Therapy and Gene Therapy CDMO Market Size by Type
2.2.3.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy and Gene Therapy CDMO Segment by Application
2.3.1 Clinical Stage Projects
2.3.2 Commercialization Stage Projects
2.3.3 Cell Therapy and Gene Therapy CDMO Market Size by Application
2.3.3.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELL THERAPY AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell Therapy and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY AND GENE THERAPY CDMO BY REGION
4.1 Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cell Therapy and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy and Gene Therapy CDMO Forecast
10.1.3 APAC Cell Therapy and Gene Therapy CDMO Forecast
10.1.4 Europe Cell Therapy and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast
10.2 Americas Cell Therapy and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cell Therapy and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cell Therapy and Gene Therapy CDMO Forecast
10.3 APAC Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cell Therapy and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.5 India Market Cell Therapy and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cell Therapy and Gene Therapy CDMO Forecast
10.4 Europe Cell Therapy and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.2 France Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.3 UK Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cell Therapy and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cell Therapy and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cell Therapy and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cell Therapy and Gene Therapy CDMO Forecast
10.6 Global Cell Therapy and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cell Therapy and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Information
11.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
11.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Pharmaceuticals Main Business Overview
11.1.5 Lonza Pharmaceuticals Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
11.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 catalent
11.3.1 catalent Company Information
11.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Offered
11.3.3 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 catalent Main Business Overview
11.3.5 catalent Latest Developments
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Information
11.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
11.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Jubilant LifeSciences Main Business Overview
11.4.5 Jubilant LifeSciences Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
11.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Information
11.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
11.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Oxford BioMedica Main Business Overview
11.6.5 Oxford BioMedica Latest Developments
11.7 Charles River
11.7.1 Charles River Company Information
11.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Offered
11.7.3 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Charles River Main Business Overview
11.7.5 Charles River Latest Developments
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Information
11.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
11.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 WuXi AppTec Main Business Overview
11.8.5 WuXi AppTec Latest Developments
11.9 He Yuan Biology
11.9.1 He Yuan Biology Company Information
11.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
11.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 He Yuan Biology Main Business Overview
11.9.5 He Yuan Biology Latest Developments
11.10 GenScript Biotech
11.10.1 GenScript Biotech Company Information
11.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
11.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 GenScript Biotech Main Business Overview
11.10.5 GenScript Biotech Latest Developments
11.11 Kanglong Chemical
11.11.1 Kanglong Chemical Company Information
11.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
11.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Kanglong Chemical Main Business Overview
11.11.5 Kanglong Chemical Latest Developments
11.12 Porton shares
11.12.1 Porton shares Company Information
11.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
11.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Porton shares Main Business Overview
11.12.5 Porton shares Latest Developments
11.13 Sano Biologics
11.13.1 Sano Biologics Company Information
11.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
11.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sano Biologics Main Business Overview
11.13.5 Sano Biologics Latest Developments
11.14 Yunzhou Biology
11.14.1 Yunzhou Biology Company Information
11.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
11.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Yunzhou Biology Main Business Overview
11.14.5 Yunzhou Biology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Gene Therapy
Table 5. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 8. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 11. Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 13. Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
Table 14. Cell Therapy and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 19. Global Cell Therapy and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell Therapy and Gene Therapy CDMO
Table 39. Key Market Challenges & Risks of Cell Therapy and Gene Therapy CDMO
Table 40. Key Industry Trends of Cell Therapy and Gene Therapy CDMO
Table 41. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lonza Pharmaceuticals Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 46. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
Table 47. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lonza Pharmaceuticals Main Business
Table 49. Lonza Pharmaceuticals Latest Developments
Table 50. Thermo Fisher Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 51. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
Table 52. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Main Business
Table 54. Thermo Fisher Latest Developments
Table 55. catalent Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 56. catalent Cell Therapy and Gene Therapy CDMO Product Offered
Table 57. catalent Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. catalent Main Business
Table 59. catalent Latest Developments
Table 60. Jubilant LifeSciences Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 61. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
Table 62. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Jubilant LifeSciences Main Business
Table 64. Jubilant LifeSciences Latest Developments
Table 65. Boehringer Ingelheim Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 66. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
Table 67. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Boehringer Ingelheim Main Business
Table 69. Boehringer Ingelheim Latest Developments
Table 70. Oxford BioMedica Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 71. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
Table 72. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Oxford BioMedica Main Business
Table 74. Oxford BioMedica Latest Developments
Table 75. Charles River Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 76. Charles River Cell Therapy and Gene Therapy CDMO Product Offered
Table 77. Charles River Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Charles River Main Business
Table 79. Charles River Latest Developments
Table 80. WuXi AppTec Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 81. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
Table 82. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. WuXi AppTec Main Business
Table 84. WuXi AppTec Latest Developments
Table 85. He Yuan Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 86. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
Table 87. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. He Yuan Biology Main Business
Table 89. He Yuan Biology Latest Developments
Table 90. GenScript Biotech Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 91. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
Table 92. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. GenScript Biotech Main Business
Table 94. GenScript Biotech Latest Developments
Table 95. Kanglong Chemical Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 96. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
Table 97. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Kanglong Chemical Main Business
Table 99. Kanglong Chemical Latest Developments
Table 100. Porton shares Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 101. Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
Table 102. Porton shares Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Porton shares Main Business
Table 104. Porton shares Latest Developments
Table 105. Sano Biologics Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 106. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
Table 107. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Sano Biologics Main Business
Table 109. Sano Biologics Latest Developments
Table 110. Yunzhou Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 111. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
Table 112. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Yunzhou Biology Main Business
Table 114. Yunzhou Biology Latest Developments
Table 1. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Gene Therapy
Table 5. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 8. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 11. Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 13. Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
Table 14. Cell Therapy and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 19. Global Cell Therapy and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell Therapy and Gene Therapy CDMO
Table 39. Key Market Challenges & Risks of Cell Therapy and Gene Therapy CDMO
Table 40. Key Industry Trends of Cell Therapy and Gene Therapy CDMO
Table 41. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lonza Pharmaceuticals Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 46. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
Table 47. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lonza Pharmaceuticals Main Business
Table 49. Lonza Pharmaceuticals Latest Developments
Table 50. Thermo Fisher Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 51. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
Table 52. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Main Business
Table 54. Thermo Fisher Latest Developments
Table 55. catalent Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 56. catalent Cell Therapy and Gene Therapy CDMO Product Offered
Table 57. catalent Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. catalent Main Business
Table 59. catalent Latest Developments
Table 60. Jubilant LifeSciences Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 61. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
Table 62. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Jubilant LifeSciences Main Business
Table 64. Jubilant LifeSciences Latest Developments
Table 65. Boehringer Ingelheim Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 66. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
Table 67. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Boehringer Ingelheim Main Business
Table 69. Boehringer Ingelheim Latest Developments
Table 70. Oxford BioMedica Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 71. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
Table 72. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Oxford BioMedica Main Business
Table 74. Oxford BioMedica Latest Developments
Table 75. Charles River Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 76. Charles River Cell Therapy and Gene Therapy CDMO Product Offered
Table 77. Charles River Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Charles River Main Business
Table 79. Charles River Latest Developments
Table 80. WuXi AppTec Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 81. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
Table 82. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. WuXi AppTec Main Business
Table 84. WuXi AppTec Latest Developments
Table 85. He Yuan Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 86. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
Table 87. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. He Yuan Biology Main Business
Table 89. He Yuan Biology Latest Developments
Table 90. GenScript Biotech Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 91. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
Table 92. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. GenScript Biotech Main Business
Table 94. GenScript Biotech Latest Developments
Table 95. Kanglong Chemical Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 96. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
Table 97. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Kanglong Chemical Main Business
Table 99. Kanglong Chemical Latest Developments
Table 100. Porton shares Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 101. Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
Table 102. Porton shares Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Porton shares Main Business
Table 104. Porton shares Latest Developments
Table 105. Sano Biologics Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 106. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
Table 107. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Sano Biologics Main Business
Table 109. Sano Biologics Latest Developments
Table 110. Yunzhou Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
Table 111. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
Table 112. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Yunzhou Biology Main Business
Table 114. Yunzhou Biology Latest Developments
LIST OF FIGURES
Figure 1. Cell Therapy and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects
Figure 11. Global Cell Therapy and Gene Therapy CDMO Market: Clinical Stage Projects (2021-2026) & ($ millions)
Figure 12. Cell Therapy and Gene Therapy CDMO in Commercialization Stage Projects
Figure 13. Global Cell Therapy and Gene Therapy CDMO Market: Commercialization Stage Projects (2021-2026) & ($ millions)
Figure 14. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 15. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 16. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell Therapy and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 22. United States Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 27. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 29. China Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 36. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 55. United States Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. China Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. India Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. France Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. UK Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 1. Cell Therapy and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects
Figure 11. Global Cell Therapy and Gene Therapy CDMO Market: Clinical Stage Projects (2021-2026) & ($ millions)
Figure 12. Cell Therapy and Gene Therapy CDMO in Commercialization Stage Projects
Figure 13. Global Cell Therapy and Gene Therapy CDMO Market: Commercialization Stage Projects (2021-2026) & ($ millions)
Figure 14. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 15. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 16. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell Therapy and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 22. United States Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 27. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 29. China Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 36. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 55. United States Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. China Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. India Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. France Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. UK Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
